Delivery Order 75F40121D00032-75F40122F19002
Award Date 9/16/22
Potential Completion Date 9/28/26
Potential Value $1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $94,074.41, was issued by the Food and Drug Administration (FDA) to Inflexxion, Inc., a for-profit organization. The contract is a Delivery Order under the FDA Prescription Drug Abuse Summary Reports Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. The task order is for a "DATA RESOURCE FOR POST-MARKETING PRESCRIPTION AND OVER-THE-COUNTER DRUG ABUSE SURVEILLANCE DATA FROM INDIVIDUALS ENTERING OR BEING ASSESSED FOR SUBSTANCE ABUSE...
- This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (HHS/FDA) to Inflexxion, Inc., a for-profit organization. The contract, with a potential value of $754,500.62, is for a DATA ENHANCEMENT PROJECT under the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The project aims to provide DATA RESOURCE FOR POST-MARKETING PRESCRIPTION AND OVER-THE-COUNTER DRUG ABUSE SURVEILLANCE DATA. The contract does...
- The Food and Drug Administration (FDA) awarded a $840,181.30 definitive contract to Brightfield Group LLC, a for-profit organization, for online data subscription and specialized analytic services. The contract, which runs from July 2021 to February 2025, is a firm fixed-price agreement with no set-aside designation. Through this contract, Brightfield Group will provide exploratory behavioral economics studies, data subscriptions, and analytical support to aid the FDA's regulatory and public...
- The U.S. Food and Drug Administration (FDA) awarded a $21,267,389.16 firm fixed price delivery order contract to Source Healthcare Analytics LLC, a global provider of outsourced development services. The contract aims to provide the FDA with access to outpatient prescription and patient-level drug utilization data over a five-year period to support the agency's drug safety monitoring efforts. This delivery order was issued under a $45 million single-award Indefinite Delivery Contract between the...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Inflexxion, Inc., a for-profit organization, to improve the quality and representativeness of the Addiction Severity Index-Multimedia Version (ASI-MV) Network. This contract, with a potential value of $1,095,103.00, is associated with the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The contract does not have a set-aside designation and...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,877,830 firm fixed price delivery order contract to Biopharma Services USA Inc. for NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS. As a foreign owned, self-certified small disadvantaged business, Biopharma Services USA will conduct the in vivo study of generic drug products in human subjects to fulfill the FDA's major program of...
- The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...
- The Food and Drug Administration (FDA) awarded a $754,024.73 firm-fixed-price contract to S-3 Research LLC, a minority-owned, self-certified small disadvantaged business, to acquire data and services to better understand consumers and potential health risks from cannabis-derived products (CDPs). The contract, which does not have a set-aside designation, has a completion date of February 12, 2027. S-3 Research is a data science company that provides research-as-a-service solutions to federal...
- <p>The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to LegitScript LLC, a for-profit limited liability company, on August 8, 2019. The $32,500.00 contract is for the availability of opioids on the surface web, with a completion date of February 8, 2020. The contract was awarded without a set-aside designation.</p>
- <p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>